​

OrthoPediatrics (KIDS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

KIDS Stock Forecast

OrthoPediatrics (KIDS) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $32.00, with a high of $32.00 and a low of $32.00. This represents a 52.60% increase from the last price of $20.97.

$20 $23 $26 $29 $32 $35 High: $32 Avg: $32 Low: $32 Last Closed Price: $20.97

KIDS Stock Rating

OrthoPediatrics stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (91.67%), 1 Hold (8.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 11 Strong Sell Sell Hold Buy Strong Buy

KIDS Price Target Upside V Benchmarks

TypeNameUpside
StockOrthoPediatrics52.60%
SectorHealthcare Stocks 33.91%
IndustryMedical Device Stocks20.97%

Price Target Trends

1M3M12M
# Anlaysts-18
Avg Price Target-$32.00$37.38
Last Closing Price$20.97$20.97$20.97
Upside/Downside-52.60%78.25%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25321--6
Mar, 25321--6
Feb, 25321--6
Jan, 25321--6
Dec, 24321--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 05, 2025Stifel Nicolaus$32.00$25.6124.95%52.60%
Oct 14, 2024Richard NewitterTruist Financial$28.00$25.579.50%33.52%
Sep 13, 2024Mike MatsonNeedham$42.00$31.6032.91%100.29%
Sep 13, 2024Kaila KrumTruist Financial$34.00$31.607.59%62.14%
Sep 06, 2024Matt O'BrienPiper Sandler$44.00$29.8847.26%109.82%
Sep 06, 2024Ryan ZimmermanBTIG$44.00$29.8847.26%109.82%
Jul 16, 2024Richard NewitterTruist Financial$35.00$34.441.63%66.91%
May 07, 2024Rick WiseStifel Nicolaus$40.00$34.7015.27%90.75%
Aug 05, 2022Truist Financial$66.00$55.0619.87%214.74%
Jul 18, 2022BTIG$61.00$42.9941.89%190.89%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 13, 2024Truist FinancialBuyBuyhold
Sep 13, 2024NeedhamBuyBuyhold
Sep 06, 2024Piper SandlerOverweightOverweighthold
Sep 06, 2024BTIGBuyBuyhold
May 07, 2024NeedhamMarket OutperformMarket Outperformhold
Mar 07, 2024Truist FinancialMarket OutperformMarket Outperformhold
Oct 04, 2023BernsteinOutperformOutperformhold
Jan 10, 2023NeedhamBuyBuyhold
Nov 01, 2022Piper SandlerOverweightOverweighthold
Oct 18, 2022GuggenheimBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.82$-0.84$0.06$-0.92$-1.64---
Avg Forecast$-1.34$-1.02$-0.71$-0.89$-1.13$-1.01$-0.70$-0.52
High Forecast$-1.32$-1.01$-0.70$-0.87$-1.09$-0.81$0.07$-0.11
Low Forecast$-1.36$-1.04$-0.72$-0.90$-1.15$-1.20$-1.33$-1.03
Surprise %35.82%-17.65%-108.45%3.37%45.13%---

Revenue Forecast

$50M $110M $170M $230M $290M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$71.08M$98.05M$122.29M$148.73M$204.73M---
Avg Forecast$72.68M$97.93M$122.30M$148.83M$203.07M$239.75M$280.87M$326.00M
High Forecast$73.44M$98.96M$123.55M$151.03M$204.13M$240.62M$280.88M$330.82M
Low Forecast$71.93M$96.92M$121.25M$147.03M$202.46M$238.94M$280.87M$322.06M
Surprise %-2.20%0.12%-0.01%-0.06%0.82%---

Net Income Forecast

$-40M $-31M $-22M $-13M $-4M $5M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-32.94M$-16.26M$1.26M$-20.97M$-37.82M---
Avg Forecast$-30.43M$-23.23M$-16.13M$-20.14M$-25.48M$-25.01M$-17.69M$-14.73M
High Forecast$-30.02M$-22.92M$-15.95M$-19.79M$-24.79M$-18.37M$1.68M$-2.60M
Low Forecast$-30.84M$-23.54M$-16.34M$-20.49M$-26.17M$-27.15M$-30.20M$-23.43M
Surprise %8.27%-30.00%-107.80%4.13%48.45%---

KIDS Forecast FAQ

Is OrthoPediatrics stock a buy?

OrthoPediatrics stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that OrthoPediatrics is a favorable investment for most analysts.

What is OrthoPediatrics's price target?

OrthoPediatrics's price target, set by 12 Wall Street analysts, averages $32 over the next 12 months. The price target range spans from $32 at the low end to $32 at the high end, suggesting a potential 52.60% change from the previous closing price of $20.97.

How does OrthoPediatrics stock forecast compare to its benchmarks?

OrthoPediatrics's stock forecast shows a 52.60% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the medical device stocks industry (20.97%).

What is the breakdown of analyst ratings for OrthoPediatrics over the past three months?

  • April 2025: 50.00% Strong Buy, 33.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 50.00% Strong Buy, 33.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 50.00% Strong Buy, 33.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is OrthoPediatrics’s EPS forecast?

OrthoPediatrics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.01, marking a -38.41% decrease from the reported $-1.64 in 2024. Estimates for the following years are $-0.7 in 2026, and $-0.52 in 2027.

What is OrthoPediatrics’s revenue forecast?

OrthoPediatrics's average annual revenue forecast for its fiscal year ending in December 2025 is $239.75M, reflecting a 17.11% increase from the reported $204.73M in 2024. The forecast for 2026 is $280.87M, and $326M for 2027.

What is OrthoPediatrics’s net income forecast?

OrthoPediatrics's net income forecast for the fiscal year ending in December 2025 stands at $-25.013M, representing a -33.87% decrease from the reported $-37.822M in 2024. Projections indicate $-17.69M in 2026, and $-14.728M in 2027.